Skip to main content
. 2017 Apr 3;12:2657–2672. doi: 10.2147/IJN.S132929

Figure 5.

Figure 5

(A) HT-29 cell inhibition by the listed SL2B treatment; (B) HT-29 cell inhibition by the combined DOX and SL2B treatment; (C) Western blotting results for the downregulation of jagged-1 that plays a key role in the Notch signaling pathway; (D) binding affinity curve of SL2B-FITC and TD-1SL2B-FITC with HT-29 cells.

Abbreviations: DOX, doxorubicin; FI, fluorescence intensity; TD, tetrahedron; FITC, fluorescein isothiocyanate.